(Total Views: 63)
Posted On: 10/03/2025 9:30:23 AM
Post# of 36727
BriaCell $BCTX will present new preclinical data on its Bria-OTS+ cancer vaccine platform at the SITC 40th Anniversary Annual Meeting (Nov 7-9). Investors should watch for insights on how Bria-OTS+ Overcomes Immune Resistance. Full PR here: https://globenewswire.com/news-release/2025/1...eting.html
(0)
(0)
